Home
Home » companies

Biogen Idec

Analysis: Drug industry bets on new blockbusters in 2013

Analysis: Drug industry bets on new blockbusters in 2013
Reuters

Banking on Biotech

Banking on Biotech
CNBC

Teva Petitions FDA To Delay Biogen MS Drug

Teva Petitions FDA To Delay Biogen MS Drug
Pharmalot

Biogen Idec Retools After ALS Drug Trial Failure

Biogen Idec Retools After ALS Drug Trial Failure
Seeking Alpha

A Leading Biotechnology Company Offering Explosive Growth

A Leading Biotechnology Company Offering Explosive Growth
The Motley Fool

Biogen Idec Submits Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B

Biogen Idec Submits Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B
Yahoo

2013 Should Be Interesting for Multiple Sclerosis Drugs

2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool

Biogen Sinks as ALS Drug Fails to Show Efficacy in Trial

Biogen Sinks as ALS Drug Fails to Show Efficacy in Trial
Bloomberg

13 Biotech Stock Predictions for 2013

13 Biotech Stock Predictions for 2013
TheStreet.com

Keep an Eye on These Five New Drugs in the First Quarter of 2013

Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville